In a meta-analysis of 13800 cancer patients and 23340 controls, consumption of olive oil (OLO) was found to be negatively related to cancer prevalence, and those who consumed the most OLO had a lower chance of developing any sort of cancer than those who consumed the least [20]. Similarly, two Mediterranean studies approved the chemo-preventive role of OLO against gastric CA [5, 19]. Also, another epidemiological study concerning 28 countries from four continents has showed the protective role of OLO on colorectal cancer (CRC) development [23]. Oleuropein (OLE) is a phenolic secoiridoid chemical that is mostly found in the leaves, fruits, and flowers of the olive tree. It is also found in the form of oleuropein aglycon in OLO. Many experimental studies revealed that OLE and its metabolite hydroxytyrosol (HT) inhibited the development of both the digestive system (colorectal, hepatic etc.) and other systemic (breast, lung, blood, brain, urogenital, skin and soft tissue) malignancies. Both OLO phenols (OLE and HT) are effective at inhibiting the growth, migration, invasion, and angiogenesis of cancerous cells. By altering a number of oncogenic signaling pathways, they also function as anticancer agents [2, 14, 15, 18]. Numerous studies examined the chemoprotective and curative properties of olive oil against colon cancer. They found that OLE and HT suppressed COX-2 and BCL-2 protein expression moreover avoided DNA damage. Thus, the start, development, and metastasis of colorectal cancer cells were all prevented by OLE and HT [7, 9, 17]. Oleuropein has been shown to have chemo-preventive effects against colon cancer in C57bl/6 mice with colitis. OLE treatment inhibited inflammatory responses, cancer initiation and tumor development via its antioxidant activity [10].
Several studies have reported the induction of apoptosis of cancer cell lines and the inhibition of malign cell proliferation by OLE [6, 24]. Another research about the effectiveness of OLE and HT on pancreatic cancer cells revealed their cytotoxicity and apoptosis in these malign cells. OLE also displayed a selective protective effect on non-tumorigenic pancreas cells [11]. Similarly, in another study on prostate cancer, OLE has shown an anti-oxidant effect in normal cells, whereas it induced pro-oxidant and anti-proliferative actions in cancer cells [1]. Moreover, OLE analogs stimulated immune (natural killer and lymphokine-activated killer lymphocytes) attacks against several malign cell lines [21]. Also, in a study related to Albino mices affected by soft tissue sarcoma, 1% OLE in drinking water provided complete tumor regression [12]. Oleuropein has also been shown to potentiate the effects of conventional chemotherapy in a number of trials [18].
Nowadays, the effectiveness and anticarcinogenic role of OLE and HT on gastric cancer cells has not been studied satisfactorily and the underlying mechanisms of its action remains yet unknown. OLE significantly reduced ROS levels, increased total antioxidant status levels, and repaired cisplatin-induced stomach cell damage in rats in an experimental investigation about the antioxidant and restorative effects of the substance [8]. Recently, synthesis of Nano-Paramagnetic Oleuropein has been reported as an inducer of KRAS Over-Expression and inhibition of G.CA Cancer Cells. Also, it could trigger apoptosis in the G.CA cell line [4].
Our study is the first research about cytotoxic, genotoxic, apoptotic and ROS generating effects of OLE on G.CA cells simultaneously. We have detected that OLE decreased G.CA cells viability nearly 70% by increasing doses to the maximum concentration (500 µmol/L). Apoptosis is a wellknown mechanism induced by OLE on cancer cells. In our study, we observed that OLE induced apoptosis and necrosis nearly 60%, associated with reduced G.CA cells viability by two methods. In parallel with the induction of apoptosis and the reduction of G.CA cell viability, intracellular ROS levels were increased 1.5 times at the maximum concentration of OLE. Several studies reported that OLE caused ROS production and ROS accumulation is involved in the apoptosis of cancer cell lines by inhibition of some mitochondrial pathways [3, 6, 16, 24]. In our study increased ROS levels in parallel to OLE doses suggest their apoptotic roles in G.CA cells. Moreover, we established that increasing doses of OLE ensured almost complete (100%) DNA damage in G.CA cells, suggesting its very successful genotoxic effect in malign cells.
In conclusion, we detected significant cytotoxic, apoptotic and genotoxic effects of oleuropein on G.CA cells. Nutrition rich olive and olive oil seems to be both protective and therapeutic against gastric cancer and oleuropein may be a new, potential chemotherapeutic agent in the next future.